Bioavailability of nasally administered progesterone**Supported by Nastech Pharmaceutical Company, Inc., Hauppauge, New York, and by a grant (RR-30) from the General Clinical Research Centers Program, Division of Resources, National Institutes of Hea (Q59485383)
Jump to navigation
Jump to search
scholarly article by John F. Steege et al published October 1986 in Fertility and Sterility
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bioavailability of nasally administered progesterone**Supported by Nastech Pharmaceutical Company, Inc., Hauppauge, New York, and by a grant (RR-30) from the General Clinical Research Centers Program, Division of Resources, National Institutes of Hea |
scholarly article by John F. Steege et al published October 1986 in Fertility and Sterility |
Statements
Bioavailability of nasally administered progesterone**Supported by Nastech Pharmaceutical Company, Inc., Hauppauge, New York, and by a grant (RR-30) from the General Clinical Research Centers Program, Division of Resources, National Institutes of Hea (English)
0 references
October 1986
0 references
46
0 references
4
0 references
727-729
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference